“in the end STEMI pathway is that there are also increased…” — Take Aurally at 35:16
“in the end STEMI pathway is that there are also increased bleeding risks with that particular drug. So it tends to be just used for patients with STEMI. I mean, I remember being, because I went to the University of Nottingham and I remember the consultants in cardiology teaching us, time is muscle with these…”
0:00
49:35